Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: Potential implications in asthma and other lung diseases
Top Cited Papers
- 1 March 2006
- journal article
- review article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 533 (1-3), 133-144
- https://doi.org/10.1016/j.ejphar.2005.12.082
Abstract
No abstract availableKeywords
This publication has 106 references indexed in Scilit:
- Matrix Metalloproteinase-12 and Cathepsin D Expression in Pulmonary Macrophages and Dendritic Cells of Cigarette Smoke-Exposed MiceInternational Archives of Allergy and Immunology, 2005
- Macrophage elastase (MMP-12): a pro-inflammatory mediator?Memórias do Instituto Oswaldo Cruz, 2005
- Interleukin-13 augments transforming growth factor-β1-induced tissue inhibitor of metalloproteinase-1 expression in primary human airway fibroblastsAmerican Journal of Physiology-Cell Physiology, 2005
- Matrix metalloproteinase expression and activity in human airway smooth muscle cellsBritish Journal of Pharmacology, 2004
- Membrane associated proteases and their inhibitors in tumour angiogenesisJournal of Clinical Pathology, 2004
- Dual Regulation of MMP-2 Expression by the Type 1 Insulin-like Growth Factor ReceptorJournal of Biological Chemistry, 2004
- PAI-1 promotes extracellular matrix deposition in the airways of a murine asthma modelBiochemical and Biophysical Research Communications, 2002
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002
- Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma☆☆☆Journal of Allergy and Clinical Immunology, 1999
- Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patientsThorax, 1997